Transvenous Lead Removal Post-Market Clinical Study

2018-10-03 08:24:23 | BioPortfolio

Published on BioPortfolio: 2018-10-03T08:24:23-0400

Clinical Trials [1542 Associated Clinical Trials listed on BioPortfolio]

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

Sudden cardiac death (SCD) remains a major cause of mortality within developed nations despite aggressive efforts to reduce its societal burden. Despite extensive clinical and genetic inve...

Safety and Performance of LeadExx LC System in Lead Extraction

The study's main purpose is to evaluate the safety and performance of the LeadExx LC System and its ability to safely extract leads. The study will enroll 10 patients scheduled for CIED l...

Bridge Occlusion Balloon in Lead Extraction Procedure

To evaluate the use of an occlusion balloon (Bridge™ Occlusion Balloon, Spectranetics) within the Superior Vena Cava in lead extraction patients.

HEAL-HF: A Cardiac Resynchronization Therapy (CRT) Outcomes Study

The literature shows that approximately 40% of individuals who receive a cardiac resynchronization therapy (CRT) device for symptomatic congestive heart failure (CHF) do not have a clinica...

University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices

A single-center registry to prospectively evaluate the safety of non-cardiac/non-thoracic magnetic resonance imaging (MRI) in patients with implanted cardiac devices (pacemakers and implan...

PubMed Articles [11808 Associated PubMed Articles listed on BioPortfolio]

Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis.

Cephalic vein cutdown (CVC) and subclavian puncture (SP) are widely used techniques for lead insertion of cardiac implantable electronic devices (CIEDs). Whether one technique is superior to the other...

Successful percutaneous lead extraction 15 years after a failed extraction attempt.

New onset of phrenic nerve palsy after laser-assisted transvenous lead extraction: a single-centre experience.

Phrenic nerve palsy (PNP) after mechanical transvenous lead extraction (TLE) was recently described for the first time. We aimed to analyse our TLE database for the presence of PNP.

Percutaneous Lead Extraction in Infection of Cardiac Implantable Electronic Devices: a Systematic Review.

In the last two decades, the increased number of implants of cardiac implantable electronic devices has been accompanied by an increase in complications, especially infection. Current recommendations ...

Comprehensive strategy to reduce the incidence of lead dislodgement for cardiac implantable electronic devices.

Lead dislodgement (LD) is a well-recognized complication during implantation of cardiac implantable electronic devices (CIED). An intra-procedural protocol, referred as reduction of lead dislodgement ...

Medical and Biotech [MESH] Definitions

The study of the electrical activity and characteristics of the HEART; MYOCARDIUM; and CARDIOMYOCYTES.

A state of elevated cardiac output due to conditions of either increased hemodynamic demand or reduced cardiac oxygen output. These conditions may include ANEMIA; ARTERIOVENOUS FISTULA; THYROTOXICOSIS; PREGNANCY; EXERCISE; FEVER; and ANOXIA. In time, compensatory changes of the heart can lead to pathological form of high cardiac output and eventual HEART FAILURE.

Use of various chemical separation and extraction methods, such as SOLID PHASE EXTRACTION; CHROMATOGRAPHY; and SUPERCRITICAL FLUID EXTRACTION; to prepare samples for analytical measurement of components.

Autosomal dominant syndrome characterized by cardiac and cutaneous MYXOMAS; LENTIGINOSIS (spotty pigmentation of the skin), and endocrinopathy and its associated endocrine tumors. The cardiac myxomas may lead to SUDDEN CARDIAC DEATH and other complications in Carney complex patients. The gene coding for the PRKAR1A protein is one of the causative genetic loci (type 1). A second locus is at chromosome 2p16 (type 2).

Types of artificial pacemakers with implantable leads to be placed at multiple intracardial sites. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles. They may or may not include defibrillating electrodes (IMPLANTABLE DEFIBRILLATORS) as well.

More From BioPortfolio on "Transvenous Lead Removal Post-Market Clinical Study"

Quick Search


Searches Linking to this Trial